Multiple mutations of the p53 gene in human mammary carcinoma.

作者: Lou Meng , Lin Lin , Hua Zhang , Mehdi Nassiri , Azorides R Morales

DOI: 10.1016/S0921-8777(99)00053-1

关键词:

摘要: Alteration of the p53 tumor suppressor gene is most common genetic abnormality in human cancer. In breast cancer, depending on stage disease and method detection, mutation rates 25-60% have been observed. Multiple mutations same however, are rarely reported. this study we explored frequency multiple mammary carcinoma a cohort south Florida patients. Three hundred eighty-four cases primary cancer diagnosed between 1984 1986 at University Miami, Jackson Medical Center were subjects study. Sequence analysis exons 5 through 8 was performed cloned PCR-amplified DNA formalin-fixed, paraffin-embedded tumors. Two thirty-four 384 cancers (61%) had mutation. Of those, 36 tumors showed more than one mutation; 31 two mutations, three three, five case carried six mutations. The majority missense (43) followed by silent (35); occurred within single exon. Our suggests that currently believed.

参考文章(28)
B. Smith-Sørensen, Eivind Hovig, M. S. Greenblatt, Therese Sorlie, R. Montesano, M. Hollstein, C. C. Harris, K. Rice, R. Fuchs, T. Soussi, Database of p53 gene somatic mutations in human tumors and cell lines. Nucleic Acids Research. ,vol. 22, pp. 3551- 3555 ,(1994)
Jorunn E. Eyfjörd, Rut Valgardsdottir, Margret Steinarsdottir, Helga M. Ögmundsdottir, Steinunn Thorlacius, Kesara Anamthawat-Jonsson, p53 abnormalities and genomic instability in primary human breast carcinomas. Cancer Research. ,vol. 55, pp. 646- 651 ,(1995)
J Harwood, A Tachibana, M Meuth, Multiple dispersed spontaneous mutations: a novel pathway of mutation in a malignant human cell line. Molecular and Cellular Biology. ,vol. 11, pp. 3163- 3170 ,(1991) , 10.1128/MCB.11.6.3163
Olga B. Chernova, Michail V. Chernov, Munna L. Agarwal, William R. Taylor, George R. Stark, The role of p53 in regulating genomic stability when DNA and RNA synthesis are inhibited Trends in Biochemical Sciences. ,vol. 20, pp. 431- 434 ,(1995) , 10.1016/S0968-0004(00)89094-5
T. Soussi, Y. Legros, R. Lubin, K. Ory, B. Schlichtholz, Multifactorial analysis of p53 alteration in human cancer: a review. International Journal of Cancer. ,vol. 57, pp. 1- 9 ,(1994) , 10.1002/IJC.2910570102
M. M. Seidman, A. Bredberg, S. Seetharam, K. H. Kraemer, Multiple point mutations in a shuttle vector propagated in human cells: evidence for an error-prone DNA polymerase activity Proceedings of the National Academy of Sciences of the United States of America. ,vol. 84, pp. 4944- 4948 ,(1987) , 10.1073/PNAS.84.14.4944
Lawrence A. Loeb, Fred C. Christians, Multiple mutations in human cancers. Mutation Research. ,vol. 350, pp. 279- 286 ,(1996) , 10.1016/0027-5107(95)00117-4
S N Rodin, G P Holmquist, A S Rodin, CpG transition strand asymmetry and hitch-hiking mutations as measures of tumorigenic selection in shaping the p53 mutation spectrum. International Journal of Molecular Medicine. ,vol. 1, pp. 191- 200 ,(1998) , 10.3892/IJMM.1.1.191
Annemarie Ziegler, David J Leffell, Subrahmanyam Kunala, Harsh W Sharma, Mae Gailani, Jeffrey A Simon, Alan J Halperin, Howard P Baden, Philip E Shapiro, Allen E Bale, None, Mutation hotspots due to sunlight in the p53 gene of nonmelanoma skin cancers. Proceedings of the National Academy of Sciences of the United States of America. ,vol. 90, pp. 4216- 4220 ,(1993) , 10.1073/PNAS.90.9.4216
Peter A. Hall, David P. Lane, p53 in tumour pathology: can we trust immunohistochemistry?--Revisited! The Journal of Pathology. ,vol. 172, pp. 1- 4 ,(1994) , 10.1002/PATH.1711720103